Literature DB >> 12654283

3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm.

Christopher A Elkins1, Hiroshi Nikaido.   

Abstract

Recent advances in structural biology have extended our understanding of the multiple drug efflux complex, AcrAB-TolC, of Escherichia coli. This tripartite complex and its homologs are the major mechanisms that give most Gram-negative bacteria their characteristic intrinsic resistance to a variety of lipophilic drugs, dyes, and detergents. Most recently, the structure of the transporter AcrB was elucidated at high resolution [Nature 419(2002)587]. It is a particularly significant achievement since integral membrane proteins are notoriously elusive structures for crystallography. The striking features of this trimeric pump, such as the presence of potential substrate-binding sites in the periplasmic domain and the possibility of direct interaction with the end of TolC tunnel, refine our understanding of the mode of action of this tripartite efflux transport complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654283     DOI: 10.1016/s1368-7646(03)00004-9

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  14 in total

1.  Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer.

Authors:  Iban Ubarretxena-Belandia; Joyce M Baldwin; Shimon Schuldiner; Christopher G Tate
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 2.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 3.  Vacuuming the periplasm.

Authors:  Olga Lomovskaya; Maxim Totrov
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.

Authors:  Govindsamy Vediyappan; Tatyana Borisova; Joe A Fralick
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

5.  Crystal structure of the multidrug efflux transporter AcrB at 3.1A resolution reveals the N-terminal region with conserved amino acids.

Authors:  Debanu Das; Qian Steven Xu; Jonas Y Lee; Irina Ankoudinova; Candice Huang; Yun Lou; Andy DeGiovanni; Rosalind Kim; Sung-Hou Kim
Journal:  J Struct Biol       Date:  2006-12-24       Impact factor: 2.867

Review 6.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

7.  Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.

Authors:  Sheng Chen; Shenghui Cui; Patrick F McDermott; Shaohua Zhao; David G White; Ian Paulsen; Jianghong Meng
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

8.  AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.

Authors:  Sylvie Baucheron; Shaun Tyler; David Boyd; Michael R Mulvey; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Interplay between two RND systems mediating antimicrobial resistance in Brucella suis.

Authors:  Fernando A Martin; Diana M Posadas; Mariela C Carrica; Silvio L Cravero; David O'Callaghan; Angeles Zorreguieta
Journal:  J Bacteriol       Date:  2009-02-06       Impact factor: 3.490

10.  pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon.

Authors:  Ana Martins; Gabriella Spengler; Liliana Rodrigues; Miguel Viveiros; Jorge Ramos; Marta Martins; Isabel Couto; Séamus Fanning; Jean-Marie Pagès; Jean Michel Bolla; Joseph Molnar; Leonard Amaral
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.